Apogee Therapeutics (NASDAQ:APGE) Now Covered by Citigroup
Citigroup began coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a research note released on Thursday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $95.00 target price on the stock. A number of other brokerages have also recently issued reports on APGE. Canaccord Genuity Group assumed coverage on Apogee […]
Citigroup began coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a research note released on Thursday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $95.00 target price on the stock. A number of other brokerages have also recently issued reports on APGE. Canaccord Genuity Group assumed coverage on Apogee […]
